Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0002016438-24-000001
Filing Date
2024-03-22
Accepted
2024-03-22 13:00:46
Documents
1
Effectiveness Date
2024-03-22
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 8623
  Complete submission text file 0002016438-24-000001.txt   9692
Mailing Address 2200 MARKET ST, SUITE 606 GALVESTON TX 77550
Business Address 2200 MARKET ST, SUITE 606 GALVESTON TX 77550 409-497-4038
Chrysalis Biotherapeutics, Inc. (Filer) CIK: 0002016438 (see all company filings)

EIN.: 611687007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-508350 | Film No.: 24774490